As a new study finds that pharma has become Washington's largest lobby in terms of dollars spent in campaign contributions, a high-stakes battle is looming in the heat of election season over what those dollars can buy. Much will depend on whether Barack Obama wins the White House with larger Democratic majorities on Capitol Hill. After eight drug industry-assisted Republican power years to harden the Democrats' attitudes, warming up Washington's new bosses won't be easy. But it will be essential.
Pages to are hidden for
"As I See It"Please download to view full document